Filters
Study Phase
Recruitment Status
Study Type
Eligibility Sex
Healthy Volunteers
Found 540544 clinical trials
Sort by:
Efficacy and Safety of Posterior Chamber Glaucoma Drainage Device
Not Applicable
Not yet recruiting
- Conditions
- Refractory Glaucoma
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Eye Hospital of Ho Chi Minh City
- Target Recruit Count
- 60
- Registration Number
- NCT07003685
Effects of Mandibular Advancing Device in Obstructive Sleep Apnea
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 25
- Registration Number
- NCT07003854
- Locations
- 🇪🇬
Faculty of dentistry AinShams University, Cairo, Abbaseya, Egypt
Rapid Antiretroviral Treatment Initiation With BIC/FTC/TAF in HIV-infected People Who Inject Drugs (PWID)
Completed
- Conditions
- HIV Positive People Who Inject Drugs
- Interventions
- Drug: bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF)
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases
- Target Recruit Count
- 37
- Registration Number
- NCT07004933
- Locations
- 🇬🇷
General Hospital of Athens "EVAGGELISMOS", Athens, Attiki, Greece
🇬🇷General Hospital of Athens "LAIKO", Athens, Attiki, Greece
🇬🇷University General Hospital "ATTIKON", Athens, Attiki, Greece
A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities
Phase 2
Recruiting
- Conditions
- Chronic Weight Management
- Interventions
- Drug: ASC30 tablets or ASC30 tablets A1 or placebo
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Ascletis Pharma (China) Co., Limited
- Target Recruit Count
- 125
- Registration Number
- NCT07002905
- Locations
- 🇺🇸
Ascletis Clinical Site, San Antonio, Texas, United States
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
Early Phase 1
Not yet recruiting
- Conditions
- Non Hodgkin Lymphoma
- Interventions
- Drug: STR-P004
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Starna Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT07003178
- Locations
- 🇨🇳
Starna, Suzhou, Jiangsu, China
Study to Investigate the Efficacy and Safety of SC0023, in Adults With Refractory or Unexplained Chronic Cough
Not Applicable
Recruiting
- Conditions
- Chronic Cough
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Kholood Altassan
- Target Recruit Count
- 20
- Registration Number
- NCT07003347
- Locations
- 🇸🇦
King Saud University Hospital, Riyadh, Saudi Arabia
A Study of DIA:CONN P8 Smart Insulin Pen With CGM-Based Coaching in Patients With Type 1 or Type 2 Diabetes
Not Applicable
Not yet recruiting
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- G2e Co., Ltd
- Target Recruit Count
- 152
- Registration Number
- NCT07004153
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Clinical Outcomes of PIMSRA Treating for Hypertrophic Obstructive Cardiomyopathy: A Large-Sample Study
Active, not recruiting
- Conditions
- Hypertrophic Obstructive Cardiomyopathy (HOCM)
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Xijing Hospital
- Target Recruit Count
- 800
- Registration Number
- NCT07003945
- Locations
- 🇨🇳
Ultrasound Medicine Department of Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 48
- Registration Number
- NCT07003542
- Locations
- 🇺🇸
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland, Ohio, United States
Effects of Progressive Muscle Relaxation Training Applied in Addition to Aerobic Exercise Training in Individuals With Migraine Diagnosis
Not Applicable
Not yet recruiting
- Conditions
- MigraineMigraine Disease
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Mardin Artuklu University
- Target Recruit Count
- 60
- Registration Number
- NCT07003711
© Copyright 2025. All Rights Reserved by MedPath